You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SSRI

Showing 26 - 50 of 783
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • San Diego, California
  • +26 more
Aug 17, 2022

MDD Trial in Fort Myers (Auricular Acupuncture, Sham Auricular Acupuncture + Lexapro)

Completed
Has Results
  • Major Depressive Disorder
  • Auricular Acupuncture
  • Sham Auricular Acupuncture + Lexapro
  • Fort Myers, Florida
    Counseling and Psychological Services
Sep 15, 2021

Healthy Young and Older Adults Trial in Berlin (procedure, drug, other)

Completed
  • Healthy Young and Older Adults
  • tDCS
  • +2 more
  • Berlin, Germany
    Charite Universitätsmedizin Berlin
May 10, 2021

Risk Factors for AD-Associated Switch to Mania

Completed
  • Bipolar Disorder
  • Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
  • Barcelona, Catalonia, Spain
    Hospital Clinic Barcelona
Nov 17, 2021

Anxiety, Separation, Anxiety, Generalized, Anxiety, Social Trial in Los Angeles, Chicago, Cincinnati (Cognitive Behavioral

Recruiting
  • Anxiety, Separation
  • +2 more
  • Cognitive Behavioral Therapy (CBT)
  • Combination therapy (COMB)
  • Los Angeles, California
  • +2 more
Sep 1, 2021

Anxiety Disorder, Healthy Trial in Tianjin (SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other

Recruiting
  • Anxiety Disorder
  • Healthy
  • SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other antidepressants or antipsychotics or other sedative-hypnotics
  • Neurofeedback system
  • Tianjin, China
    Tianjin Anding Hospital
Oct 17, 2021

Stroke, Ischemic Trial in White Plains (Administration of SSRI escitalopram, Paired Associative stimulation, Administration of

Withdrawn
  • Stroke, Ischemic
  • Administration of SSRI escitalopram
  • +2 more
  • White Plains, New York
    Burke Neurological Institute
Jul 19, 2021

Psychologic Manipulation Trial (behavioral, drug, other)

Completed
  • Psychologic Manipulation
  • Cognitive processing therapy
  • +2 more
  • (no location specified)
Mar 30, 2021

MDD Trial (SSRI + golimumab, SSRI + )

Not yet recruiting
  • Major Depressive Disorder
  • SSRI + golimumab
  • SSRI + placebo
  • (no location specified)
Aug 25, 2020

Depression Trial in Atlanta (drug, behavioral, other)

Completed
Has Results
  • Depression
  • Selective serotonin re-uptake inhibitor
  • +2 more
  • Atlanta, Georgia
    12 Executive Park Drive, 3rd floor
Oct 13, 2020

Depression Trial in Dallas (SSRI + LD, SSRI + PHD)

Completed
Has Results
  • Depression
  • SSRI + LD
  • SSRI + PHD
  • Dallas, Texas
    University of Texas Southwestern Medical Center at Dallas
Sep 1, 2020

Stroke Trial in Bordeaux, Toulouse (Fluoxetine, Placebo, fMRI)

Unknown status
  • Stroke
  • Bordeaux, France
  • +1 more
Jul 29, 2020

MDD Trial in Salt Lake City (5-Hydroxytryptophan 100 MG, Creatine monohydrate, matched to 5-HTP)

Recruiting
  • Major Depressive Disorder
  • 5-Hydroxytryptophan 100 MG
  • +3 more
  • Salt Lake City, Utah
    University of Utah Department of Psychiatry
Apr 27, 2021

Assessment of SSD in Outpatients by Using SSS-CN

Recruiting
  • Somatization Disorder
  • Deanxit, SSRI or SRNI
  • Shanghai, Shanghai, China
    Renji Hospital
Dec 6, 2020

Social Phobia Trial in Hamilton (Topiramate, Placebo)

Terminated
  • Social Phobia
  • Hamilton, Ontario, Canada
    MacAnxiety Research Centre
Aug 31, 2020

Epilepsy, SUDEP Trial in Iowa City (Fluoxetine, Placebo)

Completed
Has Results
  • Epilepsy
  • SUDEP
  • Iowa City, Iowa
  • +1 more
Apr 22, 2020

Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)

Active, not recruiting
  • Depressive Disorder, Major
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +58 more
Jan 31, 2023

Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

Not yet recruiting
  • Depression
  • Serotonin Deficiency
  • Pharmacological agent: Citalopram
  • Placebo
  • Kelowna, British Columbia, Canada
    University of British Columbia, Okanagan Campus
Jul 19, 2023

MDD Trial in Manchester, Liverpool (SPL026)

Recruiting
  • Major Depressive Disorder
  • Manchester, Greater Manchester, United Kingdom
  • +1 more
Jan 18, 2023

Depressive Disorder Trial in Changsha (sulforaphane, placedo, selective 5 - HT reuptake inhibitors (SSRI))

Unknown status
  • Depressive Disorder
  • Changsha, Hunan, China
    Mental Health Institute of Second Xiangya Hospital,CSU
Aug 18, 2020

Pharmacogenetics of Antidepressant-Induced Disinhibition

Recruiting
  • Obsessive-Compulsive Disorder
  • +3 more
    • Calgary, Alberta, Canada
      Child and Adolescent Addiction, Mental Health & Psychiatry
    Nov 4, 2022

    Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

    Completed
    Has Results
    • Depressive Disorder, Major
    • Phoenix, Arizona
    • +49 more
    Jul 20, 2022

    The Antidepressant Advisor: fMRI Study to Predict Treatment

    Completed
    • Major Depressive Disorder
      • London, United Kingdom
        King's College London, IoPPN
      Jan 4, 2023

      Depression Trial in Stony Brook (Escitalopram, Placebo)

      Completed
      Has Results
      • Depression
      • Stony Brook, New York
        Stony Brook University Hospital
      Dec 14, 2022

      Depression Trial in Winston-Salem (Fluoxetine 20 MG, Duloxetine 30 MG, Observation)

      Not yet recruiting
      • Depression
      • Fluoxetine 20 MG
      • +2 more
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      Jul 28, 2023